From: Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer
Toxicity grade 3–4
N
%
Clinical
Stomatitis
2
9
Biological
Elevated serum hepatic transaminases
4
18
Thombocytopenia
3
13.5
Neutropenia
Anemia
1
4.5